Related Experiment Video

Updated: Jun 25, 2026

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

Explaining coronary heart disease trends in Hong Kong: creation of a model for policy and planning

S M McGhee1, J C So, G N Thomas

  • 1Department of Community Medicine, The University of Hong Kong, Li Ka Shing Faculty of Medicine, Pokfulam, Hong Kong SAR, China. smmcghee@hkucc.hku.hk

Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|March 5, 2009
PubMed

Insights

Medical treatments significantly reduced coronary heart disease (CHD) deaths, more than changes in risk factors. Improving patient adherence to treatments offers further potential for lowering CHD mortality.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Epidemiology

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
  • Understanding the drivers of CHD mortality reduction is crucial for public health strategies.

Purpose of the Study:

  • To quantify the contributions of medical treatment and risk factor changes to CHD mortality reductions.
  • To assess the potential impact of improving treatment uptake on CHD mortality.

Main Methods:

  • Utilized epidemiological data and statistical modeling to analyze CHD mortality trends.
  • Differentiated the impact of medical interventions versus lifestyle/risk factor modifications.

Main Results:

  • Medical treatment accounted for the largest proportion of CHD mortality decline.
  • Changes in modifiable risk factors contributed to a smaller but significant reduction.
  • Current treatment uptake levels present an opportunity for further mortality reduction.

Conclusions:

  • Medical advancements and their effective implementation are primary drivers of reduced CHD mortality.
  • Enhancing patient adherence to prescribed medical treatments is a key strategy for future CHD prevention efforts.
  • Public health initiatives should focus on both risk factor modification and optimizing treatment utilization.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...